Episode 420 -- DOJ Announces New West Coast Health Care Fraud Strike Force
Hospice Insights Podcast - Bottom Line, Top of Mind: Compliance Checklists for Hospice and Home Health
Health-e Law Podcast, Episode 26 Pt. 1 | AI Adoption in Healthcare: Managing Data Privacy, Vendor Relationships and Governance
False Claims Act Insights - Managed Care FCA Enforcement: Risk Adjustment, AI, Kickbacks, and More
Podcast — Drug Pricing and Market Access: CMS Update With Rujul Desai
Podcast — Drug Pricing and Market Access: Highlights From Recent CMS and AHLA Conferences
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 277: M&A Trends and Growth in the Life Sciences Industry with John Erwin of Maynard Nexsen
Patients Recording Medical Visits: What Health Care Providers Need to Know
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 276: Educating the Life Sciences Workforce with Wake Tech’s Leslie Isenhour
Podcast - The New Rules of Healthcare Fraud Enforcement
Hospice Insights Podcast - Hospice Audit Updates: UPICs May Pick You for a Prepayment Review
Strategic Alignment With Collaboration Is Essential to a Life Sciences M&A Exit — Troutman Pepper Locke Podcast
AI's Hidden Power Grid: Data Centers, Subsea Cables, and the New Infrastructure Arms Race — The Good Bot: Artificial Intelligence, Health Care, and the Law
Charting a Course for Collections: Diagnosing Compliance and Privacy Risks in Medical Debt — The Consumer Finance Podcast
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 275: Strategies for Building the Life Sciences Talent Pipeline with NIIMBL’s John Balchunas
Health+Tech - Healthcare Private Equity Conference Recap
Health+Tech - From Software to Scrutiny: Navigating FDA Inspections Under the New QMSR
Health+Tech - The Perfect Storm: Cyber Threats, Regulation and AI in Healthcare
Podcast - Inside Telehealth's Growth, Regulation and Access
Health-e Law Podcast, Episode 25 | Human-in-the-Loop: Bringing AI to Skilled Nursing Facilities
The U.S. Senate passed a reconciliation package on a 52-47 vote on June 5, 2026, that will provide $70 billion in funding to support U.S. immigration enforcement agencies and their activities. After nearly 18 hours of debate...more
In Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (June 4, 2026), a unanimous Supreme Court has further clarified what it takes to plead — and ultimately prove — that a defendant induced another party to infringe a...more
On May 22, 2026, California’s Office of Health Care Affordability (OHCA) released proposed revisions to the Cost and Market Impact Review (CMIR) regulations (the “Proposed Revisions”)....more
On May 28, 2026, Illinois lawmakers approved House Bill (HB) 5000, which is poised to significantly expand Illinois’ healthcare transaction notice regime under the Illinois Antitrust Act....more
Both chambers are in session this week, with focus mostly on two items: the House taking up the Senate-passed reconciliation 2.0 bill to fund US Immigration and Customs Enforcement and US Customs and Border Patrol, and...more
Can disclosing a patient’s email address to others in an email chain be considered a breach under HIPAA? Yes, it may, depending on the particular facts involved. If a medical practice or other covered entity has only...more
On May 15, 2026, the Centers for Medicare & Medicaid Services (CMS) issued the final 2027 Notice of Benefit and Payment Parameters (the “NBPP” or “final rule”), which establishes a notable structural change to the Affordable...more
Welcome to the Second Issue of SuperVision in 2026! In this edition, we bring you the latest from the EEOC and NLRB, updates on the numerous new Virginia employment laws passed in the 2026 Legislative Session, and discuss the...more
The American Bar Association’s recent Antitrust in Healthcare Conference brought together enforcers, academic researchers, economists, and members of the bar for a lively, wide-ranging discussion of issues at the intersection...more
On May 10, 2026, the Departments of Labor, Health and Human Services, and Treasury (the “Departments”) jointly proposed a rule that would create a new category of “excepted fertility benefits” under federal law (the “Proposed...more
On June 4, 2026, Justice Ketanji Brown Jackson, writing for a unanimous Supreme Court of the United States, reversed a decision by the United States Court of Appeals for the Federal Circuit and held that Amarin Pharma, Inc....more
On May 13, 2026, the U.S. Court of Appeals for the Federal Circuit (Judges Reyna, Taranto, and Stoll) affirmed a decision of the U.S. District Court for the Northern District of West Virginia finding that defendant does not...more
The European Commission (EC) announced on May 31, 2026, that it presented a roadmap to phase out animal testing for chemical safety assessments, laying out “clear, tangible steps to ensure the transition to innovative...more
The manufacture and distribution of generic pharmaceutical drugs is a polarizing topic in the political and legal world. The manufacturing and marketing of generic versions of brand-name drugs are allowed in the United States...more
The Trump administration has decertified and defunded Hawaii’s Medicaid Fraud Control Unit (MFCU), withholding $3 million in federal funds. As detailed in a previous post, in May, the Office of Inspector General for the...more
New DOJ Health Care Fraud Unit Secures Six Trial Convictions Totaling Over $1.1 Billion - The US Department of Justice (DOJ) announced on June 4 that the National Fraud Enforcement Division’s Health Care Fraud Unit secured...more
We recently reported on a new noncompete law in Virginia, effective July 1, 2026, that requires employers to pay severance in order to enforce a noncompete agreement against an employee terminated without cause. Virginia...more
Building on our April alert regarding Colorado’s three-front AI healthcare landscape, the legislature has finalized all three tracks. The compliance picture has rapidly shifted, bringing unexpected framework changes that...more
By now most people have heard that Hikma v. Amarin, No. 24–889 (June 4, 2026), was an overall favorable decision for skinny labeling. But what are the practical takeaways? Here we outline the facts and factors considered by...more
Marijuana and its legalization remain a constant topic of conversation for employers. Depending on your state, marijuana may be legal solely for medical use or also legalized for recreational use. It remains important for...more
In a unanimous opinion by Justice Ketanji Brown Jackson, the U.S. Supreme Court held that Amarin, the developer of Vascepa® (reference listed drug), failed to plausibly allege that Hikma actively induced infringement of...more
In April 2026, a complaint alleging “one of the most egregious examples of piracy in the medical technology industry” landed on the docket of the U.S. District Court for the Eastern District of Texas....more
Key Takeaways: In Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24-889, the Supreme Court reversed the Federal Circuit and held that a generic drug manufacturer’s FDA-compliant skinny label, combined with...more
On June 4, 2026, the United States Supreme Court issued its decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. In its decision, the Supreme Court reversed the Federal Circuit, and held that Amarin’s complaint...more
The Deal - On June 2, 2026, the Federal Trade Commission (FTC) required nonprofit health system Ascension Health Alliance to divest several ambulatory surgery centers (ASCs) as a condition of closing its proposed $3.9...more
